State of the European Union’s early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020–2022)

References

• European Commission, Directorate-General for Health and Food Safety, Jongh T, Becker D, Boulestreau M, Davé A, et al. Future-proofing pharmaceutical legislation : study on medicine shortages : final report (revised). 2021.
   Google Scholar
• Chapman S, Dedet G, Lopert R. Shortages of medicines in OECD countries. Paris: OECD; 2022 Mar. https://www.oecd-ilibrary.org/social-issues-migration-health/shortages-of-medicines-in-oecd-countries_b5d9e15d-en.
   Google Scholar
• National Academies of Sciences Engineering, Medicine. Building Resilience into the Nation’s Medical Product Supply Chains. Washington, DC: The National Academies Press; 2022.
   Google Scholar
• European Parliament. Texts adopted—Shortage of medicines—how to address an emerging problem—Thursday, 17 September 2020. https://www.europarl.europa.eu/doceo/document/TA-9-2020-0228_EN.html . Accessed 14 Dec 2022.
   Google Scholar
• Ventola CLThe drug shortage crisis in the United States: causes, impact, and management strategiesP&T (Lawrenceville, NJ)201136740757
   Google Scholar
• Shukar S, Zahoor F, Hayat K, Saeed A, Gillani AH, Omer S, et al. Drug shortage: causes, impact, and mitigation strategies. Front Pharmacol. 2021;12.
   Google Scholar
• Alruthia YS, Alwhaibi M, Alotaibi MF, Asiri SA, Alghamdi BM, Almuaythir GS, et al.Drug shortages in Saudi Arabia: root causes and recommendationsSaudi Pharm J201826947951 10.1016/j.jsps.2018.05.002 30416350 6218331
   PubMed Web of Science ®Google Scholar
• Di Giorgio D, Scrofina G, Scognamiglio B, Di Carluccio N, Tulimiero R, Pietrosanto A, et al. Tackling distribution-related shortages of medicines: an Italian case study evaluated in the European Union framework. Medicine Access @ Point of Care. 2019;3:239920261985685.
   Google Scholar
• Lee J, Lee HS, Shin H, Krishnan VAlleviating drug shortages: the role of mandated reporting induced operational transparencyManag Sci20216723262339 10.1287/mnsc.2020.3857
   Web of Science ®Google Scholar
• Miljković N, Batista A, Polidori P, Kohl S, Horák PResults of EAHP’s 2019 medicines shortages surveyEur J Hosp Pharm202027202208 10.1136/ejhpharm-2020-002341 32471816 7335625
   PubMedGoogle Scholar
• Pharmaceutical Group of the European Union. PGEU Survey on Medicine Shortages 2019. Brussels: Pharmaceutical Group of European Union; 2020 p. 9. https://www.pgeu.eu/wp-content/uploads/2019/03/PGEU-Medicine-Shortages-Survey-Results-2019.pdf.
   Google Scholar
• Boshnakova A, Pannelay AA. Cancer Medicines Shortages in Europe. The Economist Intelligence Unit; 2017 p. 32. https://www.esmo.org/content/download/199478/3584846/1/Cancer-Medicines-Shortages-in-Europe.pdf.
   Google Scholar
• Gloor C, Dantes M, Graefenhain E, Pantazis A, Poole J, Pujol J, et al. An Evaluation of Medicines Shortages in Europe with a more in-depth review of these in France, Greece, Poland, Spain, and the United Kingdom [Internet]. Birgli; 2013 p. 69. Available from: https://www.eaepc.org/images/pdf/evaluation.pdf.
   Google Scholar
• European Commission. Pharmaceutical Strategy for Europe. 2020. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52020DC0761
   Google Scholar
• Finnish Medicines Agency (Fimea). Lääkkeiden saatavuus säilyi Suomessa normaalina vuonna 2020 koronapandemiasta huolimatta. http://www.fimea.fi/-/laakkeiden-saatavuus-sailyi-suomessa-normaalina-vuonna-2020-koronapandemiasta-huolimatta.
   Google Scholar
• Lehtinen J, Linnolahti J, Luhtanen P, Myllyntausta M. Lääkkeiden saatavuus Suomessa - katsaus lääkkeiden saatavuushäiriöihin. Finnish Medicines Agency (Fimea); Available from: https://urn.fi/URN:ISBN:978-952-7299-38-8.
   Google Scholar
• Vogler S, Fischer SHow to address medicines shortages: findings from a cross-sectional study of 24 countriesHealth Policy2020 10.1016/j.healthpol.2020.09.001 33032846 7505130
   PubMed Web of Science ®Google Scholar
• Finnish Medicines Agency (Fimea). Frequently Asked Questions: Shortage notification. 2021. Available from: https://www.fimea.fi/documents/542809/834141/sh_ukk_2021-07%2C+en.docx/344b3b70-8bb6-823e-db61-5a8d005c6475?t=1626762740303. Accessed 3 Aug 2023
   Google Scholar
• Hyvärinen H. Kantelu Fimean saatavuushäiriömaksuista—voiko sanktioluonteinen maksu pahentaa häiriöitä? Apteekkari. 2021. https://www.apteekkari.fi/uutiset/kantelu-fimean-saatavuushairiomaksuista-voiko-sanktioluonteinen-maksu-pahentaa-hairioita.html. Accessed 7 Oct 2022.
   Google Scholar
• Lääkkeiden saatavuushäiriöilmoitusten käsittelymaksut. Chancellor of Justice of the Government of Finland; 2022. Available from: https://oikeuskansleri.fi/-/laakkeiden-saatavuushairioilmoitusten-kasittelymaksut-1. Accessed 3 Nov 2022.
   Google Scholar
• European Medicines Agency (EMA). Shortages catalogue. 2020. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines/shortages-catalogue. Accessed 10 Oct 2022.
   Google Scholar
• Directorate-General for Health and Food Safety (European Commission), Ecorys BV, Milieu Law & Policy Consulting, Technopolis Group. Future-proofing pharmaceutical legislation: study on medicine shortages : country fiches. LU: Publications Office of the European Union; 2022. Available from: https://data.europa.eu/doi/10.2875/417613. Accessed 1 Jun 2022.
   Google Scholar
• Ravela R, Lyles A, Airaksinen MNational and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USABMC Health Serv Res202222940 10.1186/s12913-022-08309-3 35869486 9306441
   PubMed Web of Science ®Google Scholar
• Pauwels K, Huys I, Casteels M, Simoens SDrug shortages in European countries: a trade-off between market attractiveness and cost containment?BMC Health Serv Res201414438 10.1186/1472-6963-14-438 25257912 4263120
   PubMed Web of Science ®Google Scholar
• Bochenek T, Abilova V, Alkan A, Asanin B, de Beriain IM, Besovic Z, et al.Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian CountriesFront Pharmacol20188942 10.3389/fphar.2017.00942 29403372 5779072
   PubMed Web of Science ®Google Scholar
• Postma DJ, De Smet PAGM, Gispen-de Wied CC, Leufkens HGM, Mantel-Teeuwisse AK. Drug shortages from the perspectives of authorities and pharmacy practice in the Netherlands: an observational study. Front Pharmacol. 2018;9.
   Google Scholar
• European Commission. Reform of the EU pharmaceutical legislation. 2023. https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe/reform-eu-pharmaceutical-legislation_en. Accessed 28 Jun 2023.
   Google Scholar